中国P站

Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by systemic inflammation, which frequently affects the small joints of the hands and feet. Rheumatoid arthritis of the foot (RA foot) significantly impairs mobility and quality of life [1]. Early diagnosis and comprehensive management are critical for preventing joint deformity and disability. This article reviews the pathophysiology, clinical presentation, diagnostic methods, and both non-surgical and surgical treatment strategies for RA foot [2].

Rheumatoid arthritis (RA) is a systemic autoimmune disease affecting approximately 1% of the global population, with a higher prevalence in women. The disease primarily targets synovial joints, resulting in progressive inflammation, cartilage destruction, and bone erosion [3]. The foot is frequently involved, with over 90% of RA patients eventually experiencing foot and ankle symptoms. The forefoot is commonly affected initially, followed by midfoot and hindfoot involvement as the disease progresses. Rheumatoid arthritis (RA) is a chronic, systemic autoimmune disease characterized by persistent synovial inflammation, which ultimately leads to progressive joint destruction, pain, and disability [4]. While RA can affect any joint in the body, the foot and ankle are frequently involved, with nearly 90% of RA patients experiencing foot-related symptoms over the course of their disease [5]. In fact, in many cases, foot involvement can be an early manifestation of RA, sometimes preceding hand or wrist symptoms. The foot’s complex biomechanical structure and weight-bearing function make it particularly vulnerable to the destructive effects of chronic inflammation, resulting in both functional impairment and diminished quality of life. The pathophysiology of RA in the foot involves an autoimmune cascade where immune dysregulation leads to synovial inflammation and pannus formation [6]. This abnormal tissue proliferates, eroding adjacent cartilage, ligaments, and bone. Over time, the structural integrity of the foot deteriorates, causing characteristic deformities such as hallux valgus, hammer toes, and pes planus. These deformities not only impair mobility but also contribute to secondary complications, including calluses, ulcerations, and gait abnormalities.

Accurate diagnosis of RA in the foot requires a combination of clinical evaluation, imaging studies, and laboratory tests. Early identification is critical, as prompt intervention can slow disease progression and preserve joint function [7]. Radiographic imaging, including X-rays, ultrasound, and magnetic resonance imaging (MRI), can detect early inflammatory changes and joint damage. Serological markers such as rheumatoid factor (RF) and anti-citrullinated protein antibodies (ACPA) also play a crucial role in confirming the diagnosis and guiding treatment decisions. Management of RA in the foot involves a multidisciplinary approach, encompassing pharmacologic therapies, physical therapy, orthotic support, and in advanced cases, surgical intervention. Disease-modifying antirheumatic drugs (DMARDs) remain the cornerstone of medical treatment, aiming to reduce inflammation and prevent joint damage. Biologic agents have revolutionized the therapeutic landscape by targeting specific inflammatory pathways; thereby offering improved disease control and symptom relief. Non-pharmacologic interventions, such as custom orthotics, footwear modifications, and physical therapy, are essential for reducing pain and optimizing foot function [8]. In severe cases with extensive joint destruction or deformity, surgical procedures such as joint fusion (arthrodesis) or joint replacement (arthroplasty) may be necessary to restore mobility and alleviate pain.

As RA is a progressive and systemic condition, the involvement of the foot can significantly impair mobility, independence, and overall quality of life. Therefore, understanding the pathophysiology, diagnostic modalities, and management strategies specific to the foot is vital for providing comprehensive and effective care to individuals affected by this debilitating disease.

Pathophysiology of RA in the foot

RA is driven by autoimmune dysregulation, resulting in chronic synovitis and joint destruction. The key pathological processes include:

Synovial inflammation- The synovium becomes hyperplastic and infiltrated with immune cells, including T cells, B cells, and macrophages.

Pannus formation- The inflamed synovium proliferates and invades cartilage and bone, contributing to joint erosion.

Osteoclast activation- Pro-inflammatory cytokines (TNF-8, IL-1, and IL-6) stimulate osteoclasts, promoting bone resorption.

Cartilage degradation- Proteolytic enzymes, such as matrix metalloproteinases (MMPs), degrade cartilage matrix, leading to joint space narrowing and deformity.

Foot involvement in RA manifests with the following symptoms and deformities:

Pain and swelling- Persistent pain, particularly in the metatarsophalangeal (MTP) joints, is common.

Morning stiffness- Stiffness lasting more than 30 minutes, typically in the morning, is a hallmark feature.

Gait abnormalities- Progressive joint damage leads to altered gait mechanics, including antalgic gait and reduced walking speed.

Hallux valgus- The great toe deviates laterally due to chronic joint instability.

Hammertoe and claw Toe- Flexion contractures of the proximal interphalangeal (PIP) or distal interphalangeal (DIP) joints.

Forefoot splaying- Widening of the forefoot due to MTP joint instability.

Flatfoot deformity- Midfoot and hindfoot collapse due to progressive ligament laxity.

Accurate diagnosis of RA foot involves clinical assessment, imaging studies, and laboratory testing.

Inspection and palpation- Check for swelling, deformities, and tenderness over MTP, PIP, and ankle joints.

Foot function tests- Assess gait, weight-bearing capacity, and balance.

Pressure distribution studies- Detect abnormal plantar pressures and risk of foot ulceration.

X-rays- Identify joint space narrowing, bone erosion, and deformities.

Ultrasound- Detects synovitis, effusion, and early erosions.

MRI- Provides detailed soft tissue and bone visualization, revealing synovial hypertrophy and marrow edema.

Rheumatoid factor (RF) and anti-cyclic citrullinated peptide (anti-CCP) - Positive in 70-80% of RA cases.

ESR and CRP- Indicators of systemic inflammation.

HLA-DR4 and HLA-DR1 Testing- Genetic markers associated with RA susceptibility.

Treatment and management

The management of RA foot involves a multidisciplinary approach, including pharmacological treatment, physical therapy, and surgical intervention.

Methotrexate (first-line therapy) reduces synovial inflammation and prevents joint damage.

Leflunomide, sulfasalazine, and hydroxychloroquine are alternative options.

TNF inhibitors (etanercept, adalimumab) and IL-6 inhibitors (tocilizumab) reduce inflammation.

Intra-articular corticosteroid injections provide temporary relief in cases of severe synovitis.

Symptomatic management of pain and inflammation.

Foot orthoses- Custom-made orthotic insoles reduce plantar pressure and improve gait.

Footwear modifications- Rocker-bottom shoes and wide-toe shoes alleviate pain.

Physical therapy- Strengthening exercises, stretching, and proprioceptive training enhance foot stability.

Surgical treatment

Surgery is considered in cases of severe deformity or functional impairment.

Synovectomy- Removal of inflamed synovial tissue to reduce pain.

Arthrodesis (joint fusion) - Fusion of damaged joints, particularly in the hindfoot, to restore stability.

Joint replacement- Total ankle replacement or MTP joint replacement in advanced RA cases.

Tendon transfer- Corrects muscle imbalances and deformities.

Untreated or poorly managed RA foot can lead to severe disability. Common complications include-

Joint ankylosis- Fusion of the joint due to chronic inflammation.

Foot ulcers- Secondary to abnormal weight distribution and reduced mobility.

Reduced quality of Life- Impaired mobility and chronic pain significantly affect daily activities.

Conclusion

Rheumatoid arthritis of the foot is a disabling condition requiring early diagnosis and comprehensive management. Pharmacological therapy, physical interventions, and surgical options can mitigate pain, preserve function, and enhance patients’ quality of life. Timely intervention and a multidisciplinary approach are essential for optimal outcomes in RA foot patients.